Schedule 13G ownership disclosure

LYRA THERAPEUTICS INC

Security class unavailable · CUSIP: 55234L105

Event date: 2023-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,175,832
Percent of class
13.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-005703
Form type
SC 13G
Filer
CARGO Therapeutics, Inc.
CIK
CIK 1966494
Filed
Nov 24, 2023
Reporting period
Nov 14, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub